RXO INC RXO
19.79
(0.14)
(0.70%)
as of 25 Sep
- Market cap
- $3.3B
- P/E
- 0.0×
Follow RXO
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.77 | 0.43 | 0.37 | 0.44 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(117.01) | (353.19) | 304.19 | 112.73 | |
P/B ratio |
3.11 | 1.64 | 1.38 | 1.64 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.85 | 0.51 | 0.44 | 0.50 | |
EV/EBITDA |
172.02 | 87.83 | 68.01 | 49.51 | |
EV/Operating CF |
(303.56) | 63.01 | 49.34 | 80.29 | |
EV/FCF |
(68.81) | (222.95) | (419.39) | (174.75) | |
Quick Ratio |
1.19 | 1.18 | 1.20 | 1.24 | |
Current Ratio |
1.27 | 1.27 | 1.27 | 1.32 | |
Net Debt/EBITDA |
17.78 | (213.00) | (27.64) | 19.89 | |
Debt/Assets |
14.31% | 13.68% | 12.33% | 12.59% | |
Debt/Equity |
0.33 | 0.30 | 0.26 | 0.26 | |
Asset Turnover |
1.83 | 1.75 | 1.72 | 1.80 | |
Operating CF/Net income |
4.44 | 0.19 | (0.15) | (1.64) | |
Capex/Depreciation |
(0.46) | (0.65) | (0.54) | (0.54) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
11.89% | 13.82% | 13.61% | 14.64% | |
Intangible Assets out of Total Assets |
0.45 | 0.48 | 0.48 | 0.50 | |
Share Based Compensation of Revenue |
0.39% | 0.49% | 0.48% | 0.56% | |
Graham Net Nets |
(0.08) | (0.17) | (0.20) | (0.16) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(2.21%) | (4.17%) | (4.59%) | (3.15%) | |
Free Cash Flow Yield |
(1.60%) | (0.53%) | (0.28%) | (0.66%) | |
Revenue per Share |
10.46 | 8.43 | 8.72 | 8.43 | |
Operating CF per Share |
(0.24) | (0.04) | 0.04 | 0.14 | |
Capex per Share |
(0.07) | (0.10) | (0.09) | (0.08) | |
Free Cash Flow per Share |
(0.31) | (0.14) | (0.05) | 0.05 | |
Cash per Share |
0.09 | 0.12 | 0.10 | 0.15 | |
Shareholders Equity per Share |
8.88 | 8.92 | 9.15 | 9.37 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
8.88 | 8.92 | 9.15 | 9.37 | |
Free Cash Flow |
(52.00) | (24.00) | (8.00) | 9.00 | |
Working Capital |
329.00 | 287.00 | 279.00 | 294.00 | |
Capital Expenditures |
(12.00) | (17.00) | (15.00) | (14.00) | |
Net Current Asset Value |
(397.00) | (424.00) | (419.00) | (420.00) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
(0.51%) | (2.53%) | (3.13%) | (0.99%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
1,254.50 | 1,183.00 | 1,226.50 | 1,121.00 | |
Average Payables |
587.00 | 541.00 | 553.50 | 526.50 | |
Average Assets |
3,330.00 | 3,286.00 | 3,345.50 | 3,296.50 | |
Average Common Equity |
1,547.00 | 1,548.00 | 1,576.50 | 1,616.00 |
Columns are period end dates